Elliot Norry, Chief Medical Officer at Adaptimmune Therapeutics PLC (ADAP), sold 849 shares at $4.06 ($3K) on 2022-01-04, disclosed to the SEC on 2022-01-05.
Open-market sale of $3k ADAP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADAP | SELL | 2024-01-17 | $14K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $10K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $4K | — | Filing → |